BLRX (BioLine Rx) Short Interest


BLRX BioLine Rx Ltd BLRX
23 GF Score
Price $3.07
! 5 Warning Signs
View Full Analysis

What is BioLine Rx Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BLRX vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, BioLine Rx's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLine Rx Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLine Rx's Short Interest distribution charts can be found below:

* The bar in red indicates where BioLine Rx's Short Interest falls into.


BLRX
23GF Score
BioLine Rx Ltd BLRX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioLine Rx Business Description

Other Exchanges BLRX:IsraelYP2:Germany
Address 2 HaMa’ayan Street, Modi’in, ISR, 7177871
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
23GF Score

Get the complete analysis for BLRX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.07
Price